M22: Diagnostic Microbiology Flashcards
The Clinical Microbiology Laboratory
- Priorities
a. Accurately diagnose pathogens: _ + _.
b. Sufficient _ to aid in patient care. - Challenges
a. Manage _ per day.
b. Manage data from _.
c. Maintain _ with quality control. - Rapid Diagnostic Test
a. High _, high _ predictive value, _.
a. detection + identification.
b. speed
a. large numbers of samples
b. individual samples
c. accuracy
a. High sensitivity/specificity, high positive/negative predictive value, reproducible.
Traditional Technologies:
Staining
a. e.g. (3)
b. Advantages: (2)
c. Disadvantages: (2)
Gram stain
acid-fast stain
India ink preparation
Rapid
very inexpensive detection.
Lower sensitivity for detection
not usually specific identification
Traditional Technologies:
Culture-based (bacteria)
a. e.g. (2)
b. Advantages: (3)
c. Disadvantages: (2)
MacConkey agar
eosin methylene blue (EMB)
high detection sensitivity
more information on identification
relatively inexpensive.
overnight culture required
still not species-specific information.
Traditional Technologies:
Culture-based (virus)
a. e.g. (2)
b. Advantages: (1)
c. Disadvantages: (3)
cytopathic effect
immunofluorescent staining
specific identification (especially immunofluorescent staining)
Slow
expensive
difficult to grow.
Traditional Technologies:
Biochemicals
a. e.g. _ (catalase, oxidase, PYR test), _ (tubes, API strips, Vitek cards)
b. Advantages: (1)
c. Disadvantages: (2)
tests on colonies
culture tests
species-specific identification
Sometimes ambiguous results or strain has atypical behavior,
expense with more sophisticated automation.
Newer Technologies:
Antigen testing
a. e.g. (2)
b. Advantages: (1)
c. Disadvantages: (1)
PBP2a agglutination (MRSA) influenza and RSV rapid antigen tests
extremely fast (compare with viral culture)
for viral antigens - low sensitivity varying by specimen collection methodology and duration of illness
Newer Technologies:
Nucleic acid amplification testing (NAAT)
a. e.g. (5)
b. Advantages: (3)
c. Disadvantages: (6)
type IV SCCmec (MRSA) Neisseria gonorrhoeae Chlamydia trachomatis HSV endpoint PCR or real time PCR
more rapid than culture
very specific
quantitative (e.g. viral load)
cost labor intensive technically challenging concerns over contamination slow if sample sent to reference lab and/or if samples batched for a run not necessarily as sensitive as culture.
Newer Technologies:
Nucleic acid amplification testing (NAAT)
Rapid TB diagnostic
i. Meant to be deployed in _.
ii. High sensitivity of detecting _ cases = earlier than weeks of culture
Multiplex PCR
i. e.g. _: 12 viruses
ii. e.g. _: 22 common bloodstream pathogens (bacteria, fungi), results 6 hours, 300 colony forming units/ml
iii. e.g. _: 24 pathogens and 3 antimicrobial resistance genes identified after blood cultures turn positive. FDA approved June 2013.
16S rRNA sequencing:
i. Uses _ against conserved sequences flanking variable segments.
ii. Sequence PCR product.
iii. Most commonly identification of pathogens with isolates that have _ biochemical phenotypes.
iv. Capable of detecting _ or _ pathogens, especially if unable to culture.
developing world
AFB stain negative
Luminex xTAG Respiratory Virus Panel (UPMC)
SeptiFast real time PCR
BioFire Blood Culture Identification Panel
primers
atypical
poorly described or unknown
Newer Technologies:
Mass Spectrometry
3 components:
i. _ (ion source)
ii. measure _ (mass analyzer)
iii. abundance of _ (mass detector)
e. g.
i. _: measure PCR products; distinguish microorganisms by abundance of each nucleotide (not sequence).
ii. _: measure most abundant proteins from colonies; distinguish isolates by pattern of peaks.
vaporization
mass-to-charge ratio
molecule
PLEX-ID
Vitek MS
Newer Technologies:
Mass Spectrometry
Advantages: (3)
Disadvantages: (4)
rapid analysis
very general (any pathogen?)
direct from patient sample (PLEX-ID)
requires overnight culture (Vitek MS)
sample prep (PLEX-ID)
setup expense
sensitivity?